These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 34498750)
1. Cutaneous metastasis of primary diffuse large B-cell lymphoma of the central nervous system developing 4 years after complete remission: Diagnosis confirmed by comparison of clones. Patel BM; Moesch J; Karunamurthy A; Puleio DV; Drappatz J; Akilov OE; Kazlouskaya V J Cutan Pathol; 2022 Jan; 49(1):90-94. PubMed ID: 34498750 [TBL] [Abstract][Full Text] [Related]
2. Adrenal relapse of primary central nervous system diffuse large B-cell lymphoma: A case report. Ma S; Sen SS; Jug R; Zhang X; Zhang WL; Shen S; Yu CQ; Xu HT; Yang LH; Wang E Medicine (Baltimore); 2018 Sep; 97(38):e12482. PubMed ID: 30235749 [TBL] [Abstract][Full Text] [Related]
3. Rare cases of primary central nervous system anaplastic variant of diffuse large B-cell lymphoma. Xu T; Jia Q; Wang Y; Liu Y; Han D; Li P; Ma J; Fan L; Yan Q; Guo S; Li M; Wang Z Diagn Pathol; 2019 May; 14(1):45. PubMed ID: 31109360 [TBL] [Abstract][Full Text] [Related]
4. Clinical utility of brain biopsy for presumed CNS relapse of systemic lymphoma. Brown DA; Goyal A; Richter KR; Haglin JM; Himes BT; Lu VM; Snyder K; Hughes J; Decker PA; Opoku-Darko M; Link MJ; Burns TC; Parney IF J Neurosurg; 2022 Jan; 136(1):30-39. PubMed ID: 34214988 [TBL] [Abstract][Full Text] [Related]
5. Primary Intra-Axial Diffuse Large B-Cell Lymphoma in Immunocompetent Patients: Clinical Impact of Molecular Analysis and Histogenetic Evaluation. Cambruzzi E World Neurosurg; 2020 Feb; 134():215-220. PubMed ID: 31605845 [TBL] [Abstract][Full Text] [Related]
6. Primary cerebral diffuse large B-cell lymphoma relapsed solely in the skin with the same clonal origin. Chuang SS; Liu H; Huang Y; Chio CC; Lin LC Appl Immunohistochem Mol Morphol; 2009 Jan; 17(1):77-81. PubMed ID: 19115486 [TBL] [Abstract][Full Text] [Related]
7. Secondary Cutaneous Diffuse Large B-cell Lymphoma has a Higher International Prognostic Index Score and Worse Prognosis Than Diffuse Large B-cell Lymphoma, Leg Type. Lee WJ; Won KH; Won CH; Chang SE; Choi JH; Moon KC; Park CS; Huh J; Suh C; Lee MW Acta Derm Venereol; 2016 Feb; 96(2):245-50. PubMed ID: 26014205 [TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor II mRNA binding protein 3 is highly expressed in primary diffuse large B-cell lymphoma of the CNS. Odani K; Fujimoto M; Fujii H; Saka M; Mizoguchi K; Hirata M; Sakurai T; Takeuchi Y; Minamiguchi S; Arakawa Y; Haga H J Clin Exp Hematop; 2024; 64(3):203-207. PubMed ID: 39343609 [TBL] [Abstract][Full Text] [Related]
9. Primary cutaneous diffuse large B-cell lymphoma (PCDLBCL), leg-type and other: an update on morphology and treatment. Paulli M; Lucioni M; Maffi A; Croci GA; Nicola M; Berti E G Ital Dermatol Venereol; 2012 Dec; 147(6):589-602. PubMed ID: 23149705 [TBL] [Abstract][Full Text] [Related]
10. Can cutaneous low-grade B-cell lymphoma transform into primary cutaneous diffuse large B-cell lymphoma? An immunohistochemical study of 82 cases. Plaza JA; Kacerovska D; Sangueza M; Schieke S; Buonaccorsi N; Suster S; Kazakov DV Am J Dermatopathol; 2014 Jun; 36(6):478-82. PubMed ID: 24698933 [TBL] [Abstract][Full Text] [Related]
11. A Case of Transformation of Primary Cutaneous Follicle Center Lymphoma to Diffuse Large B-Cell Lymphoma Involving the Parotid Gland and Cervical Lymph Nodes. King ML; Vengaloor Thomas T; Albert AA; Joseph S; Ramachandran Nair L; Lam JT; Woods WC; Nittala M; Vijayakumar S Am J Case Rep; 2019 Aug; 20():1273-1278. PubMed ID: 31462626 [TBL] [Abstract][Full Text] [Related]
12. Primary cutaneous Epstein-Barr virus-positive diffuse large B-cell lymphoma: a rare and aggressive cutaneous lymphoma. Vermeesch J; Ramirez J; Lafond A Cutis; 2018 Dec; 102(6):421-424. PubMed ID: 30657800 [TBL] [Abstract][Full Text] [Related]
13. Primary central nervous system diffuse large B-cell lymphoma shows an activated B-cell-like phenotype with co-expression of C-MYC, BCL-2, and BCL-6. Li X; Huang Y; Bi C; Yuan J; He H; Zhang H; Yu Q; Fu K; Li D Pathol Res Pract; 2017 Jun; 213(6):659-665. PubMed ID: 28552541 [TBL] [Abstract][Full Text] [Related]
14. [Diffuse large B-cell lymphoma developed newly after 9-year remission of a follicular lymphoma]. Hirano T; Tsuji T; Yamasaki H; Toyozumi Y; Arima N; Tsuda H Rinsho Ketsueki; 2016 Feb; 57(2):171-4. PubMed ID: 26935635 [TBL] [Abstract][Full Text] [Related]
15. Primary cutaneous Epstein-Barr virus-positive diffuse large B-cell lymphoma, not otherwise specified, in a nonimmunocompromised young man: A case report. Mo XL; Zhou MY; Ye QR J Cutan Pathol; 2020 Apr; 47(4):387-389. PubMed ID: 31658378 [TBL] [Abstract][Full Text] [Related]
16. A Case of CD5-Positive Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type Secondary to Chronic Lymphedema. Sun L; Sun Y; Xin W; He J; Hu Y; Zhang H; Yu J; Zhang JA Am J Dermatopathol; 2022 Mar; 44(3):179-182. PubMed ID: 35171885 [TBL] [Abstract][Full Text] [Related]
17. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study. Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700 [TBL] [Abstract][Full Text] [Related]
18. Intravascular large B-cell lymphoma with cutaneous manifestations: a clinicopathologic, immunophenotypic and molecular study of three cases. Kong YY; Dai B; Sheng WQ; Yang WT; Wang CF; Kong JC; Shi DR J Cutan Pathol; 2009 Aug; 36(8):865-70. PubMed ID: 19040469 [TBL] [Abstract][Full Text] [Related]
19. De Novo CD5-Positive Diffuse Large B-Cell Lymphoma: Report of a Case Presenting With Cutaneous Involvement and Featuring Extensive Intravascular Dissemination on Postmortem Examination. Úbeda Romero A; Santonja C; Blanco García A; Requena L; Rodríguez Pinilla SM Int J Surg Pathol; 2016 Dec; 24(8):763-768. PubMed ID: 27431754 [TBL] [Abstract][Full Text] [Related]
20. [Survival of patients with primary central nervous system diffuse large B-cell lymphoma: impact of gene aberrations and protein overexpression of bcl-2 and C-MYC, and selection of chemotherapy regimens]. Yin WJ; Zhu X; Yang HY; Sun WY; Wu MJ Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):32-38. PubMed ID: 29325248 [No Abstract] [Full Text] [Related] [Next] [New Search]